CBD and cannabis news in brief: United States

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Colorado
Florida
Indiana
Maine
New Jersey
New York
North America
North Dakota
Tennessee
United States
Regulation and Legislation
Regulatory briefing
The first in a new weekly round-up from around the US brings you news from Colorado, Florida, Indiana, Maine, New Jersey, New York, North Dakota, and Tennessee ...

CBD and cannabis news in brief: International

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Asia
Canada
India
North America
World
Companies
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Regulatory briefing
The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station ...

CBD and cannabis news in brief: Europe

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Belgium
Czech Republic
EU
Europe
Germany
Lithuania
Netherlands
Switzerland
Policy and Politics
Regulation and Legislation
Regulatory briefing
The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU ...

When will CBD foods be legal in the US? Don’t hold your breath

Written by CBD-Intel || 25th April 2019 || Regulatory briefing |

North America
United States
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased ...

Big dollars are undeterred by red tape tangle and inconsistent enforcement

Written by CBD-Intel || 11th March 2019 || Business briefing |

Canada
North America
United States
Companies
Marketing and Retailing
Public Health and Medicine
Business briefing
North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses ...

CBD to treat concussion disorders? Retired NHL players join study

Written by CBD-Intel || 8th March 2019 || Business briefing |

Canada
North America
United States
Companies
Public Health and Medicine
Technology and Innovation
Business briefing
A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders ...

FDA sets the date for hearing on legalising hemp-derived CBD

Written by CBD-Intel || 1st March 2019 || Regulatory briefing |

California
Maine
North America
United States
Wisconsin
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner...

Deal signals plans for ‘sustainable’ bio-synthesised CBD

Written by CBD-Intel || 26th February 2019 || Business briefing |

North America
United States
Companies
Business briefing
The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for creating synthetic sweeteners...

Cannabis companies team up with pharma firm to supply Europe

Written by CBD-Intel || 14th February 2019 || Business briefing |

Canada
Europe
Greece
North America
Poland
United States
Companies
Business briefing
Two of the largest legal cannabis companies, Wayland and International Cannabis Corp, are teaming up with a multinational pharmaceutical organisation in a bid to create significant amounts of CBD for the European market ...